HRT Tablet vs Patch for Perimenopause: Pros, Cons, and How to Choose
HRT tablets and patches both treat perimenopause symptoms but differ in safety, convenience, and dosing. Compare the pros and cons of each delivery method.
Why Delivery Method Matters in HRT
When you start hormone replacement therapy for perimenopause, one of the first decisions your doctor will discuss is how to deliver the hormones. Tablets and patches are the two most commonly prescribed options, and while they both supply estrogen (and sometimes progestogen) to your body, they get there by very different routes. That difference in route matters for your safety profile, how well symptoms are controlled, and practical day-to-day factors. Understanding the distinctions can help you ask better questions and make a decision that fits your health history and lifestyle.
How HRT Tablets Work
Oral HRT tablets are swallowed and absorbed through the digestive system before entering the bloodstream. This means the hormones pass through the liver first, a process called first-pass metabolism. Liver processing changes how estrogen behaves in the body, particularly affecting clotting factors and other proteins the liver produces. Oral estrogen has been associated with a small but measurable increase in the risk of blood clots (venous thromboembolism) and stroke, largely because of this liver effect. Tablets are convenient, familiar, and widely available. They come in combined forms containing both estrogen and progestogen, which is simpler to manage than separate preparations. They are generally the least expensive option and are covered by most insurance plans and national health systems.
How HRT Patches Work
Transdermal estrogen patches are worn on the skin and deliver hormones directly into the bloodstream through the skin, bypassing the liver. This is a significant safety advantage: because the liver is not involved in first-pass processing, transdermal estrogen does not increase clotting factors in the same way oral estrogen does. Multiple large studies, including data from the Women's Health Initiative and UK observational research, have shown that transdermal estrogen does not carry the same elevated blood clot and stroke risk as oral estrogen. This makes patches the preferred option for women with a personal or family history of blood clots, high blood pressure, or migraines with aura. Patches typically need to be changed once or twice a week. They come in estrogen-only formulations (suitable for women without a uterus) or in combined forms, and some women use an estrogen patch alongside a separate progestogen such as micronized progesterone.
Safety: The Most Important Difference
The cardiovascular and clotting risk difference between oral and transdermal HRT is the most clinically significant distinction. Current guidance from the British Menopause Society, the North American Menopause Society, and most major menopause organizations recommends transdermal estrogen as the preferred route for women who have risk factors for blood clots, heart disease, or stroke. For healthy women with no relevant risk factors, both routes are considered safe when started before age 60 or within ten years of menopause, but the transdermal route is still generally considered to carry lower absolute risk. Women who take progestogen alongside their estrogen (anyone with a uterus) should know that the type of progestogen also matters: micronized progesterone has a more favorable safety profile compared to synthetic progestogens for breast cancer and cardiovascular risk.
Symptom Control and Dosing Flexibility
Both tablets and patches effectively reduce hot flashes, night sweats, mood disturbance, and sleep disruption when used at appropriate doses. Patches come in a wider range of doses and it is easier to make small, gradual dose adjustments with patches than with tablets, which come in more fixed dose steps. This flexibility is useful during perimenopause when hormone needs may fluctuate as the transition progresses. Some women find that patches provide more stable symptom control because they deliver a relatively consistent level of hormone rather than a peak-and-trough pattern that can occur with once-daily tablets. Others find they get equally good symptom relief with tablets and prefer not to deal with patch adherence issues.
Practical Considerations
Tablets are simpler to start with: you take one daily, just like any other pill. No skin irritation, no worrying about the patch falling off during a swim or in the bath. Patches require consistent placement on clean, dry skin and can sometimes peel at the edges or cause localized skin reactions. Not everyone finds them practical for active lifestyles. Some women report that certain patch brands adhere better than others and that rotating placement sites reduces skin irritation. Tablets can sometimes cause nausea, particularly when starting, and must be taken at a consistent time of day. Both forms are available without a visit to a specialist for most women, though a prescription is required.
Which One Is Right for You
If you have any history of blood clots, stroke, high blood pressure, liver disease, or migraines with aura, a patch is almost certainly the better choice for you, and your doctor should prioritize transdermal delivery. If you are otherwise healthy and prefer the simplicity of a daily tablet, the safety difference is smaller, though many menopause specialists now recommend patches as the default for most women based on their overall favorable risk profile. A useful starting point is to discuss your full health history with your doctor and ask specifically whether the transdermal route would be more appropriate for your situation. Most women find that one form works significantly better for their skin, symptoms, and routine than the other, and it is reasonable to try both before settling on a long-term approach.
Related reading
Get your personalized daily plan
Track symptoms, match workouts to your day type, and build a routine that adapts with you through every phase of perimenopause.